Adaptive Biotechnologies ADPT
NASDAQ ADPT
$28.60 +0.93 (+3.36%)
As of: Sep 17, 2026 · 3:59 PM EDT

Adaptive Biotechnologies (ADPT) Share-based Compensation Growth (3y) (2021 - 2026)

Analysis

Adaptive Biotechnologies (ADPT) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 32.51%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -20.63%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -7.98%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 37.19%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn -4.11%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn -13.78%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 12.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.78%
Mar 31, 2026 -6.90%
Dec 31, 2025 -3.81%
Sep 30, 2025 2.81%
Jun 30, 2025 -2.33%
Mar 31, 2025 -6.82%
Dec 31, 2024 2.62%
Sep 30, 2024 1.94%
Jun 30, 2024 -0.01%
Mar 31, 2024 1.82%
Dec 31, 2023 29.02%
Sep 30, 2023 -0.39%
Jun 30, 2023 2.40%
Mar 31, 2023 -5.45%
Dec 31, 2022 61.22%
Sep 30, 2022 -6.82%
Jun 30, 2022 -11.72%
Mar 31, 2022 70.19%
Dec 31, 2021 57.39%
Sep 30, 2021 69.96%